Weight Loss & MetabolicEmerging Evidence

AOD-9604 Peptide Therapy

Benefits, Side Effects, Cost & Protocols

AOD-9604 peptide molecular structure diagram from PubChem

AOD-9604 is a lipolytic 16-amino acid peptide fragment of human growth hormone, consisting of HGH residues 176-191. Initial human trials showed it retains the lipolytic properties of growth hormone without stimulating IGF-1 production. Its development was terminated in 2007 after later studies failed to demonstrate sufficient lipolytic effect.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated May 19, 2026

Clinically Reviewed

Reviewed by Alex Evans, PharmD, MBA · Updated May 2026

Evidence-Based

Sourced from FDA, PubMed & ClinicalTrials.gov · View sources

FDA Status

Banned from Compounding March 2024 Removed from compounding nomination list. HGH fragment not eligible for compounding.

Evidence

Emerging Evidence

Who Is AOD-9604 Best For?

Fat metabolismLipolysis supportBody compositionPrimarily animal or early-phase data

How AOD-9604 Works

HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.

AOD-9604 FAQ

What is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone (HGH) specifically researched for its potential lipolytic (fat-burning) effects without the growth-promoting properties of full HGH.

How does AOD-9604 work?

HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.

Is AOD-9604 legal to buy?

AOD-9604 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy AOD-9604?

AOD-9604 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.

What category does AOD-9604 belong to?

AOD-9604 is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.

What are the research benefits of AOD-9604?

AOD-9604 has been studied for: Fat metabolism, Lipolysis support, Body composition. HGH fragment focused on lipolysis.

Key Studies

16 total on PubMed13 human trials

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

J Am Acad Orthop Surg Glob Res Rev

Therapeutic peptides reviewed for orthopaedic applications and future directions

Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls

J Pharm Biomed Anal

Review of analytical methods for detecting emerging therapeutics and non-approved drugs in doping controls

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions

Expert Rev Proteomics · Expert Rev Proteomics

Review of current methods and future directions for detecting peptidic drugs in sports doping

Obesity drugs in clinical development

Curr Opin Investig Drugs · Curr Opin Investig Drugs

Survey of obesity drug candidates and therapeutics in clinical development pipeline

Gateways to clinical trials

Methods Find Exp Clin Pharmacol · Methods Find Exp Clin Pharmacol

Gateway approaches to clinical trial design and methodology

AOD-9604 Compound Data

Molecular Formula

C78H123N23O23S2

Molecular Weight

1815.1 g/mol

IUPAC Name

(2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-methyl-butanoyl]amino]-5-oxo-pentanoyl]amino]-13-(2-carboxyethyl)-22-(3-guanidinopropyl)-7,19-bis(hydroxymethyl)-16-isopropyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenyl-propanoic acid

View full compound on PubChem

AOD-9604 News

AOD 9604 Peptide: Expert Analysis Reviews Benefits and Side Effects for 2026 - Yahoo Finance

Yahoo Finance · 5 months ago

RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work. - ProPublica

ProPublica · 1 month ago

The expanding research landscape of a Lipolytic Peptide - Pulse Kenya

Pulse Kenya · 12 days ago

AOD-9604 Peptide: Exploring Its Potential Influence in Scientific Research - Mid-day

Mid-day · 3 months ago

AOD-9604 Peptide: Unlocking Its Potential in Metabolic and Regenerative Research - Health Tech World

Health Tech World · 12 months ago

The Peptide Craze - Ground Truths | Eric Topol

Ground Truths | Eric Topol · 10 months ago

What is the drug AOD-9604? - Australian Broadcasting Corporation

Australian Broadcasting Corporation · 155 months ago

Everything You Need to Know About the FDA Peptide Ban - Hone Health

Hone Health · 26 months ago

News aggregated via Google News. Inclusion does not imply endorsement.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications.All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Ready to explore AOD-9604 with a provider?

Take our 2-minute quiz to get matched with a board-certified provider specializing in AOD-9604.

Take the Quiz →